SUN-550 CARF Through Its Lipid Lowering Effect May Play a Pivotal Role in the Development of Non-Alcoholic Fatty Liver Diseases

por Hasan, Kamrul M, Parveen, Meher, Pena, Alondra, Sinha-Hikim, Amiya P, Friedman, Theodore C
Publicado 2020

CARF (CDKN2AIP) Regulates Hepatic Lipid Metabolism and Protects Against Development of Non-Alcoholic Fatty Liver Diseases

por Hasan, Kamrul M, Parveen, Meher, Pena, Alondra, Calles, Erick Galdamez, Gergis, Marvy, Espinoza-Derout, Jorge, Sinha-Hikim, Amiya, Friedman, Theodore C
Publicado 2021

RF32 | PSUN44 CARF Regulates Non-Alcoholic Fatty Liver Diseases (NAFLD) by Controlling ER Stress and Lipogenesis in Hepatic Cells.

por Friedman, Theodore, Sinha-Hikim, Amiya, Hasan, Kamrul, Pena, Alondra, Parveen, Meher, Wilson, Julian, Lao, Candice, Camano, Juan Carlos Rivera, Espinoza-Derout, Jorge
Publicado 2022

Fatty Acid Excess Dysregulates CARF to Initiate the Development of Hepatic Steatosis

por Hasan, Kamrul M., Parveen, Meher, Pena, Alondra, Bautista, Francisco, Rivera, Juan Carlos, Huerta, Roxana Ramirez, Martinez, Erica, Espinoza-Derout, Jorge, Sinha-Hikim, Amiya P., Friedman, Theodore C.
Publicado 2023